Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme.

An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Abstract Text:

    Utilising the Scotland and Newcastle Lymphoma Group population data for Hodgkin's disease (HD), collected over a 20-year period, it is evident that 20% of patients are over the age of 60 yr at diagnosis. Data from 674 patients are available. This group comprised 346 men and 328 women. Median follow-up was 9.5 yr. In total 361 patients had stage I/II disease. In this cohort overall response and complete response (CR) rates were 88% and 79%, respectively, for treated patients. Overall 308 patients had stage III/IV disease. Among treated patients in this cohort, overall and CR rates were 78% and 59%, respectively. Response data were missing for 26 patients with stage I/II disease and 43 patients with stage III/IV disease. The chlorambucil, vinblastine, procarbazine and prednisolone, mechlorethamine, vincristine, probarbazine and prednisolone and doxorubicin, bleomycin, vinblastine and decarbazine were the commonest chemotherapy regimens, in descending order of frequency, used to treat this cohort of patients. Outcome did not vary with these regimens. Thirty-four other chemotherapy combinations were used, some curative others palliative. These data and all other published studies confirm the need for a prospective, age-defined approach to HD in the elderly. Such an approach needs to be closely linked to issues of comorbidity, an assessment of frailness and the tailoring of specific protocols for the elderly to allow full dose delivery. The Study of Hodgkin Lymphoma In the Elderly/Lymphoma Database programme has now been launched and attempts to address these issues (http://www.shieldstudy.co.uk).

    An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Publishing Authors By Initials

    For similar diagnosis: diagnostic techniques and procedures: neoplasm staging research abstracts see: diagnosis: diagnostic techniques and procedures: neoplasm staging research

    PUBMED ID PMID:

    MEDLINE DATE:

    An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: European journal of haematology. Supplementum

    VOLUME:

    Page Numbers: 63-7

    Journal Abbreviation:

    ISSN: 0902-4506

    DAY: 26

    MONTH: Jul

    YEAR: 2005

    An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8703474

    An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Keywords Mesh Terms:

    KEYWORDS: Neoplasm Staging

    MESH TERMS: therapy

    Chemical & Substance for Abstract: An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme.

    AFFILIATION: Department of Academic Haematology, Medical School, University of Newcastle, Newcastle upon Tyne, UK. s.j.proctor@ncl.ac.uk

    Country: Denmark

    Denmark Research PublicationDenmark Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur J Haematol Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News